Resistance to EGFR inhibitors in non-small cell lung cancer: Clinical management and future perspectives
Resistance to EGFR inhibitors in non-small cell lung cancer: Clinical management and future perspectives is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Resistance to EGFR inhibitors in non-small cell lung cancer: Clinical management and future perspectives have?
Resistance to EGFR inhibitors in non-small cell lung cancer: Clinical management and future perspectives has 70 citations in the OpenAlex counts ScholarIQ stores.
When was Resistance to EGFR inhibitors in non-small cell lung cancer: Clinical management and future perspectives published?
Resistance to EGFR inhibitors in non-small cell lung cancer: Clinical management and future perspectives has 2018 year in the ScholarIQ index.
What is the open-access status of Resistance to EGFR inhibitors in non-small cell lung cancer: Clinical management and future perspectives?
Resistance to EGFR inhibitors in non-small cell lung cancer: Clinical management and future perspectives has closed oa status in the ScholarIQ index.
What is the DOI of Resistance to EGFR inhibitors in non-small cell lung cancer: Clinical management and future perspectives?
The DOI for Resistance to EGFR inhibitors in non-small cell lung cancer: Clinical management and future perspectives is on the source record.
What is the PMID of Resistance to EGFR inhibitors in non-small cell lung cancer: Clinical management and future perspectives?
The PMID for Resistance to EGFR inhibitors in non-small cell lung cancer: Clinical management and future perspectives is on the source record.
What is the OpenAlex record for Resistance to EGFR inhibitors in non-small cell lung cancer: Clinical management and future perspectives?
The OpenAlex for Resistance to EGFR inhibitors in non-small cell lung cancer: Clinical management and future perspectives is on the source record.